Core Viewpoint - The legal opinion letter confirms that Beijing Chunzhi Technology Co., Ltd.'s differentiated dividend distribution complies with relevant laws and regulations, and it does not harm the interests of the company and its shareholders [6]. Group 1: Differentiated Dividend Distribution - The company approved a share repurchase plan on January 31, 2024, allowing for the repurchase of shares at a price not exceeding 30 yuan per share, with a maximum duration of 12 months [2][3]. - As of the date of the legal opinion, the company had repurchased a total of 1,059,500 shares, which will not participate in the profit distribution [3][4]. - The differentiated dividend plan was approved on May 26, 2025, proposing a cash dividend of 2.5 yuan per 10 shares to all shareholders, excluding the repurchased shares [4][5]. Group 2: Calculation Basis for Differentiated Dividend - As of June 23, 2025, the total share capital was 203,266,279 shares, with a closing price of 33.97 yuan per share [5]. - The actual distribution calculation results in a reference price of 33.72 yuan per share after accounting for the cash dividend [5]. - The impact of the differentiated dividend on the reference price is minimal, calculated to be approximately 0.0039% [5]. Group 3: Legal Compliance - The legal opinion asserts that the differentiated dividend distribution adheres to the Company Law, Securities Law, and relevant regulatory guidelines, ensuring no detriment to the company or its shareholders [6].

北京市竞天公诚律师事务所上海分所 关于 南京医药股份有限公司 差异化分红 法律意见书 上海市徐汇区淮海中路 1010 号嘉华中心 45 层 邮编：200031 Suite 45/F, K.Wah Centre, 1010 Huaihai Road (M), Xuhui District, Shanghai 200031, China 电话/Tel: +86 21 5404 9930 传真/Fax: +86 21 5404 9931 网址/Website: http://www.jingtian.com 二〇二五年六月 北京市竞天公诚律师事务所上海分所 法律意见书 北京市竞天公诚律师事务所上海分所 关于南京医药股份有限公司 差异化分红之法律意见书 致：南京医药股份有限公司 根据《中华人民共和国公司法》 （以下简称"《公司法》"）、 《中华人民共和国 证券法》 （以下简称"《证券法》"）、 《上市公司股份回购规则》 （以下简称"《回购 师事务所从事证券法律业务管理办法》和《律师事务所证券法律业务执业规则（试 行）》等规定以及在本法律意见书出具日之前已经发生或存在的事实出具法律意 见。本所已经严格履行了法定职责，遵 ...

Core Viewpoint - The legal opinion letter from Shanghai Dongfang Huayin Law Firm confirms that the differentiated dividend distribution plan proposed by Guodian Nari Technology Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][6]. Group 1: Reasons for Differentiated Dividend - On October 19, 2023, the company approved a plan to repurchase A-shares using self-owned funds between RMB 5 billion and RMB 10 billion, with a maximum repurchase price of RMB 34.05 per share, to be completed within 12 months [3][4]. - As of May 31, 2025, the company had repurchased 7,882,583 shares, accounting for 0.098% of the total share capital [3][4]. - The shares held in the repurchase account do not participate in profit distribution, leading to a difference in the total share capital for the dividend distribution [4]. Group 2: Differentiated Dividend Plan - The company plans to distribute a cash dividend of RMB 0.435 per share (tax included) to all shareholders, excluding the shares held in the repurchase account [4][5]. - The actual participating share capital for the dividend distribution is calculated to be 8,001,351,712 shares after excluding the repurchased shares [5][6]. Group 3: Calculation Basis for Differentiated Dividend - The closing price of the company's stock on June 5, 2025, was RMB 22.11 per share, with the total share capital before the dividend distribution being 8,032,088,259 shares [5][6]. - The impact of the repurchased shares on the ex-dividend reference price is minimal, calculated to be less than 1% [6]. Group 4: Conclusion - The legal opinion concludes that the differentiated dividend distribution plan is in accordance with the Company Law, Securities Law, and other relevant regulations, ensuring the protection of the interests of the company and its shareholders [6].

Core Viewpoint - The company Xinjiang Tianrun Dairy Co., Ltd. is implementing a differentiated dividend distribution plan for the year 2024, which involves cash dividends and excludes stock dividends or capital reserve transfers [1][2]. Group 1: Reasons for Differentiated Dividend - The company approved a share repurchase plan on February 23, 2022, to buy back shares for employee stock ownership plans or equity incentives, repurchasing a total of 4,799,955 shares, which is 1.50% of the total share capital at that time [1]. - The total amount spent on the share repurchase was approximately RMB 61.33 million, with a repurchase price range between RMB 11.78 and RMB 13.50 per share [1]. Group 2: Differentiated Dividend Plan - The company plans to distribute a cash dividend of RMB 0.21 per 10 shares (including tax) to all shareholders, resulting in a total cash dividend distribution of approximately RMB 6.62 million after excluding the shares held in the repurchase account [2]. - The total share capital as of April 17, 2025, is 320,190,246 shares, and the shares in the repurchase account do not have rights to profit distribution [2]. Group 3: Calculation Basis for Differentiated Dividend - The actual participating share capital for the dividend distribution is 315,403,648 shares after deducting the repurchased shares [3]. - The reference price for ex-dividend trading is calculated based on the previous closing price minus the cash dividend, with no change in circulating shares due to the nature of the dividend [3][5]. Group 4: Sponsor's Verification Opinion - The sponsor, CITIC Securities, confirms that the differentiated dividend distribution complies with relevant laws and regulations, and does not harm the interests of the listed company or all shareholders [4].

公司于2025年4月28日召开公司第二届董事会第十五次会议、第二届监事会 第十一次会议，会议审议通过了《关于公司2024年度利润分配方案的议案》， 并同意将该利润分配方案提交公司2024年年度股东大会审议。 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为上 海宣泰医药科技股份有限公司（以下简称"宣泰医药"或"公司"）首次公开发行 股票并上市保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第 11 号— —持续督导》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运 作》《上海证券交易所上市公司自律监管指引第7 号——回购股份》等有关规定， 对宣泰医药2024 年度利润分配所涉及的差异化分红（以下简称"本次差异化分红" ）相关事项进行了审慎核查，具体情况如下： 一、本次差异化分红的原因 公司于2024年2月19日召开第二届董事会第八次会议，审议通过了《关于以 集中竞价交易方式回购公司股份方案的议案》，同意公司以自有资金通过上海 证券交易所股票交易系统以集中竞价交易方式回购公司已发行的部分人民币普 通股（A股） ...

证券代码：603628 证券简称：清源股份 公告编号：2025-041 清源科技股份有限公司 债券代码：113694 债券简称：清源转债 清源科技股份有限公司2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 每股分配比例 A 股每股现金红利0.066元（含税） ? 相关日期 ? 差异化分红送转：是 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经清源科技股份有限公司（以下简称"公司"）2025 年 5 月 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东（公 司回购专用账户除外）。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关 规定，公司回购专用账户中的股份不参与本次利润分配。 （1）本次差异化分红方案 股份类别 股权登记日 最后交易日 除权（息）日 现金红利发放日 Ａ股 2025/6/26 － 2025/6/27 2025/6/27 ...

Core Viewpoint - The company has announced a differentiated dividend distribution plan, proposing a cash dividend of 0.3 yuan per share, which was approved at the 2024 annual shareholders' meeting on May 20, 2025 [1][2]. Dividend Distribution Plan - The company plans to distribute profits based on the total share capital minus the shares held in the repurchase account, with a proposed cash dividend of 3.00 yuan for every 10 shares held (including tax) [2]. - As of the announcement date, the total share capital is 179,378,265 shares, with 52,880,876.40 yuan allocated for cash dividends (including tax) [2]. - The cash dividend per share is calculated as approximately 0.2948 yuan, based on the adjusted total share capital [2]. Relevant Dates - The key dates for the dividend distribution are the record date, ex-dividend date, and cash dividend payment date [4]. Implementation of Distribution - Shares held in the company's repurchase account will not participate in profit distribution [4]. - All shares are now freely tradable, and dividends will be distributed through the China Securities Depository and Clearing Corporation Limited [4]. Taxation on Dividends - For individual shareholders holding shares for over one year, the dividend income is exempt from personal income tax, with a cash dividend of 0.30 yuan per share [5]. - For shares held for less than one year, the company will not withhold personal income tax at the time of distribution, but tax will be calculated upon transfer of shares [5]. - The tax burden varies based on the holding period, with a 20% tax for holdings of one month or less, and a 10% tax for holdings between one month and one year [6]. - For qualified foreign institutional investors (QFII), a 10% withholding tax applies, resulting in a net cash dividend of 0.27 yuan per share [6]. - Hong Kong investors will also receive a net cash dividend of 0.27 yuan per share after a 10% withholding tax [6]. Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the board office at 0571-56660370 [7].

Group 1 - The company has approved a share repurchase plan using its own funds ranging from RMB 25 million to RMB 50 million, with a maximum repurchase price of RMB 53.31 per share, aimed at employee stock ownership plans or equity incentives [1][2] - As of August 16, 2024, the company has repurchased a total of 1,291,428 shares, which will not participate in profit distribution, leading to a differentiated dividend distribution for the fiscal year 2024 [2] - The actual number of shares participating in the profit distribution is 38,708,572 shares, calculated by deducting the repurchased shares from the total share capital of 40 million shares [2][3] Group 2 - The company plans to distribute a cash dividend of RMB 1.00 per 10 shares (including tax) based on the adjusted total share capital after accounting for repurchased shares [2] - The cash dividend per share is calculated to be RMB 0.1, with the reference price for ex-dividend trading set at RMB 39.62 per share, reflecting minimal impact from the repurchased shares on the market price [3] - The sponsor institution confirms that the differentiated dividend distribution complies with relevant regulations and does not harm the interests of the company or its shareholders [3]

东方证券股份有限公司（以下简称"保荐机构"）作为重庆西山科技股份有 限公司（以下简称"西山科技"或"公司"）首次公开发行股票并上市持续督导 保荐机构，根据《公司法》《证券法》《上市公司股份回购规则》《上海证券交易 所上市公司自律监管指引第 7 号——回购股份》《上海证券交易所上市公司自律 监管指南第 2 号——业务办理》等有关规定，对公司 2024 年度利润分配所涉及 的差异化分红（以下简称"本次差异化分红"）相关事项进行了审慎核查，具体 情况如下： 一、本次差异化分红的原因 公司于 2023 年 12 月 25 日召开第三届董事会第二十三次会议，审议通过了 《关于以集中竞价交易方式回购公司股份方案的议案》，同意公司使用自有资金 以集中竞价交易方式回购公司股份用于员工持股计划或股权激励，回购金额不低 于人民币 5,000 万元（含），不超过人民币 10,000 万元（含），回购价格不超过 截至 2024 年 6 月 17 日，公司完成本次回购，已实际回购公司股份 1,312,721 月内。 股，占当时公司总股本 53,001,466 股的比例为 2.48%，支付的资金总额为人民币 议通过了《关于变更回购股份用 ...

Core Viewpoint - The legal opinion issued by Beijing Guantao (Hangzhou) Law Firm confirms that Zhejiang Kang En Bei Pharmaceutical Co., Ltd.'s differentiated dividend distribution plan for the year 2024 complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [8]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the company's net profit of RMB 405,473,540.71 for 2024, with a 10% legal surplus reserve of RMB 40,547,354.07 being deducted [6][7]. - The company plans to distribute a cash dividend of RMB 1.50 (including tax) for every 10 shares to all shareholders, calculated based on the total share capital after excluding the shares held in the repurchase account [6][7]. Group 2: Share Repurchase Details - The company announced a share repurchase plan with a total fund of no less than RMB 200 million and no more than RMB 400 million, with the repurchase period set for six months from the board's approval date [4][5]. - As of July 21, 2024, the company completed the repurchase of 63,579,048 shares, accounting for 2.47% of the total share capital, with an average repurchase price of RMB 4.72 per share [5][6]. Group 3: Legal Compliance and Conclusion - The law firm confirms that the differentiated dividend distribution adheres to the Company Law, Securities Law, and other relevant regulations, ensuring that it does not harm the interests of the company and its shareholders [8]. - The legal opinion is intended solely for the purpose of the differentiated dividend distribution and must not be used for any other purpose without prior written consent from the law firm [3].